Press Releases

Bothell, WA - FUJIFILM Sonosite, Inc. -- Richard Fabian has been promoted to the role of Chief Executive Officer (CEO) of FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, effective July 1, 2022. Richard joined the company as President and Chief Operating Officer in 2017.

“Richard has demonstrated the ability to lead FUJIFILM Sonosite through challenging times to produce outstanding results,” said General Manager of FUJIFILM Medical Systems Business Division and FUJIFILM Sonosite, Inc., Chairman Masataka Akiyama. “Richard and his leadership group have worked with the entire FUJIFILM Sonosite team to develop and launch two next-generation ultrasound systems over the last three years, breaking sales and production records in the process.”

During his tenure, FUJIFILM Sonosite developed and released two new ultrasound systems, the Sonosite PX in 2020 and the Sonosite LX in 2022. In the midst of a global pandemic, the Sonosite PX...

Clinicians will help investigate the role of point-of-care ultrasound (POCUS) technology in patients with COVID-19.

Bothell, WA — FUJIFILM Sonosite, Inc. , the world leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation , the charitable foundation of the American College of Chest Physicians , announced two recipients of the CHEST Foundation’s Research Grant in Ultrasonography and COVID-19 today. The grants include $30,000 in support and FUJIFILM Sonosite’s newly launched Sonosite PX ultrasound system for the study of POCUS efficacy in diagnosing and treating COVID-19 patients in the intensive care unit (ICU).

As of late- January 2021 , COVID-19 has claimed over 2.1 million lives and infected well over 100 million people across the world. Initial studies report that POCUS’ real-time imaging, mobility and multiple uses provides clinicians with a technology that could be used for the diagnosis, treatment and follow-up care of patients...

Bothell, WA – September 3, 2020 — FUJIFILM Sonosite, Inc. , specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, today announced that the company has received 510(k) Clearance from the U.S. Food & Drug Administration (FDA) for the company’s entire POCUS portfolio to support healthcare providers in performing accurate lung and cardiac imaging in COVID-19 patients.

Fujifilm Sonosite creates point-of-care ultrasound systems and medical informatics solutions along with transducers and accessories that can help physicians improve time-to-diagnosis, patient outcomes, procedural efficiency, and workflow.

“POCUS has emerged as a critical tool to support clinicians in their tireless efforts to evaluate lung and cardiac complications of COVID-19,” said Diku Mandavia, MD, FACEP, FRCPC, Senior Vice President and Chief Medical Officer of FUJIFILM Sonosite, Inc. “We’re very pleased that Fujifilm Sonosite’s POCUS portfolio has received this clearance from the FDA and most...

Company demonstrates suite of imaging and educational solutions to more than 14,000 anaesthesia professionals

Bothell, WA, October 17, 2019 (Booth # 641) – FUJIFILM Sonosite, Inc. , specialists in developing cutting-edge, point-of-care ultrasound (POCUS), and part of the greater Fujifilm Healthcare portfolio, will exhibit numerous solutions designed to aid healthcare professionals in a variety of anaesthetic procedures including ultrasound-guided needle placements and nerve blocks at ANAESTHESIOLOGY 2019, the American Society of Anaesthesiology’s annual meeting (ASA 2019) held October 19-23, 2019, at the Orange County Convention Centre in Orlando, Florida.

“Anaesthesiologists and nurse anaesthetists are progressively using ultrasound-guided needle placement to improve operating efficiency while decreasing placement complications and patient discomfort,” said Rich Fabian, President and Chief Operating Officer of FUJIFILM Sonosite, Inc. “As our society continues to fight the opioid epidemic, we’re proud to educate ASA attendees on pain management alternatives , such as ultrasound-guided nerve...